360 Capital has announced the closing of €85 million for Poli360 2, its second deeptech technology transfer fund, targeting a total of €100 million.

French VC Partech closed its inaugural Partech Impact Fund, securing €300 million in total commitments to scale European B2B tech transforming global value chains.

BioInnovation Institute (BII), a non-profit foundation incubating and accelerating world-class innovation, announced that eleven new companies entered its Venture Lab acceleration program.

Emerald Technology Ventures, a globally recognized venture capital firm with two decades of water-sector leadership, announced reaching the €100 million milestone for its Global Water Fund II.

Amatera, a Paris-based biotechnology company, announced the closing of its latest funding round of €6 million in equity. The round was co-led by Demea Sustainable Investment (ex-Demeter) and Oyster Bay Venture Capital, with participation from existing investors - PINC, Mudcake, and Exceptional Ventures.

German-based healthtech company Oska Health announced an €11 million seed funding round, led by Capricorn Partners and SwissHealth Ventures.

nyra Health, developer of an AI-powered platform for neurological therapy, has successfully closed a €20 million Series A funding round.

The Gates Foundation has awarded a $5 million grant to Axmed, a Swiss health-tech startup modernizing how essential medicines are procured across emerging markets.

Lifeaz, a startup based in France that aims to make defibrillators more widely available to households and organizations, has raised €13 million.

Sable Bio, a London-based AI startup focused on drug safety, has raised $3.75 million in seed funding to scale its platform that helps pharmaceutical companies identify safety risks earlier in drug discovery.